NL1030485A1 - Nieuwe verbindingen. - Google Patents

Nieuwe verbindingen.

Info

Publication number
NL1030485A1
NL1030485A1 NL1030485A NL1030485A NL1030485A1 NL 1030485 A1 NL1030485 A1 NL 1030485A1 NL 1030485 A NL1030485 A NL 1030485A NL 1030485 A NL1030485 A NL 1030485A NL 1030485 A1 NL1030485 A1 NL 1030485A1
Authority
NL
Netherlands
Prior art keywords
new connections
connections
new
Prior art date
Application number
NL1030485A
Other languages
English (en)
Other versions
NL1030485C2 (nl
Inventor
Paul Vincent Fish
Thomas Ryckmans
Alan Stobie
Florian Wakenhut
Gavin Alistair Whitlock
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NL1030485A1 publication Critical patent/NL1030485A1/nl
Application granted granted Critical
Publication of NL1030485C2 publication Critical patent/NL1030485C2/nl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/10Drugs for disorders of the urinary system of the bladder
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10Drugs for genital or sexual disorders; Contraceptives for impotence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/14Nitrogen atoms not forming part of a nitro radical

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Reproductive Health (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
NL1030485A 2004-11-23 2005-11-22 Nieuwe verbindingen. NL1030485C2 (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0425766 2004-11-23
GBGB0425766.3A GB0425766D0 (en) 2004-11-23 2004-11-23 Novel compounds

Publications (2)

Publication Number Publication Date
NL1030485A1 true NL1030485A1 (nl) 2006-05-24
NL1030485C2 NL1030485C2 (nl) 2006-11-07

Family

ID=33548739

Family Applications (2)

Application Number Title Priority Date Filing Date
NL1030485A NL1030485C2 (nl) 2004-11-23 2005-11-22 Nieuwe verbindingen.
NL1032760A NL1032760C2 (nl) 2004-11-23 2006-10-27 Nieuwe verbindingen.

Family Applications After (1)

Application Number Title Priority Date Filing Date
NL1032760A NL1032760C2 (nl) 2004-11-23 2006-10-27 Nieuwe verbindingen.

Country Status (26)

Country Link
EP (1) EP1817281A1 (nl)
JP (1) JP4233596B2 (nl)
KR (1) KR100886294B1 (nl)
CN (1) CN101065355A (nl)
AP (1) AP2007004003A0 (nl)
AR (1) AR052243A1 (nl)
AU (1) AU2005308534A1 (nl)
BR (1) BRPI0518486A2 (nl)
CA (1) CA2589258A1 (nl)
CR (1) CR9171A (nl)
EA (1) EA011217B1 (nl)
GB (1) GB0425766D0 (nl)
GT (1) GT200500337A (nl)
IL (1) IL183191A0 (nl)
MA (1) MA29038B1 (nl)
MX (1) MX2007006138A (nl)
NL (2) NL1030485C2 (nl)
NO (1) NO20072486L (nl)
PA (1) PA8653501A1 (nl)
PE (1) PE20061056A1 (nl)
SV (1) SV2006002311A (nl)
TN (1) TNSN07201A1 (nl)
TW (1) TWI300776B (nl)
UY (1) UY29224A1 (nl)
WO (1) WO2006056884A1 (nl)
ZA (1) ZA200703910B (nl)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH628885A5 (en) * 1978-01-01 1982-03-31 Anphar Sa Piperidine derivative
CA2530159C (en) * 2003-06-17 2010-02-02 Pfizer Inc. N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenaline re-uptake inhibitors
GB0314054D0 (en) * 2003-06-17 2003-07-23 Pfizer Ltd Amide derivatives as selective serotonin re-uptake inhibitors

Also Published As

Publication number Publication date
KR100886294B1 (ko) 2009-03-04
EA011217B1 (ru) 2009-02-27
NL1032760A1 (nl) 2006-12-13
MA29038B1 (fr) 2007-11-01
TWI300776B (en) 2008-09-11
PE20061056A1 (es) 2006-11-08
AU2005308534A1 (en) 2006-06-01
EA200700920A1 (ru) 2007-12-28
GT200500337A (es) 2006-06-13
NL1032760C2 (nl) 2007-04-17
NL1030485C2 (nl) 2006-11-07
KR20070086599A (ko) 2007-08-27
WO2006056884A1 (en) 2006-06-01
AR052243A1 (es) 2007-03-07
BRPI0518486A2 (pt) 2008-11-18
NO20072486L (no) 2007-06-20
UY29224A1 (es) 2006-06-30
JP4233596B2 (ja) 2009-03-04
MX2007006138A (es) 2007-07-19
SV2006002311A (es) 2006-09-14
TW200626543A (en) 2006-08-01
AP2007004003A0 (en) 2007-06-30
CA2589258A1 (en) 2006-06-01
CR9171A (es) 2007-07-04
EP1817281A1 (en) 2007-08-15
PA8653501A1 (es) 2006-06-02
GB0425766D0 (en) 2004-12-22
CN101065355A (zh) 2007-10-31
IL183191A0 (en) 2007-08-19
TNSN07201A1 (fr) 2008-11-21
ZA200703910B (en) 2008-09-25
JP2008520646A (ja) 2008-06-19

Similar Documents

Publication Publication Date Title
NL300935I2 (nl) guselkumab.
NL1028927A1 (nl) Nieuwe verbindingen.
NL1028967A1 (nl) 4-Fenylamino-chinazoline-6-yl-amiden.
NO20051522D0 (no) Kabelskjotbeskytter.
DE602005022897D1 (de) Piperidinylamino-thienoä2,3-dü-pyrimidinverbindungen
NO20053210D0 (no) Linneslakkompensator.
NO20051199L (no) Rorhandteringsutstyr.
NL1026438A1 (nl) Nieuwe verbindingen.
NO20052746D0 (no) Avlopsenhet.
NO20053362L (no) Syklofuge.
NO20041374D0 (no) Bolgekraftverk.
NO20052482D0 (no) Redningskokong.
NO20040762L (no) Stromskinne.
NL1028622A1 (nl) Stelwig.
NL1032760A1 (nl) Nieuwe verbindingen.
NL1025196A1 (nl) Hark-Zeef-Vork.
ES1057865Y (es) Desatascador de desagues.
ES1057779Y (es) Tenso-papelera.
ES1059191Y (es) Candelero tritubular.
ES1058279Y (es) Cantonera.
ES1058195Y (es) Expositor -botellero.
ES1057922Y (es) Vitrina frigorifica polivalente.
ES1057217Y (es) Canape elevable.
ES1059938Y (es) Paleta batefuegos escalonada.
NO20041511D0 (no) Energiomvandlingssystem.

Legal Events

Date Code Title Description
AD1A A request for search or an international type search has been filed
RD2N Patents in respect of which a decision has been taken or a report has been made (novelty report)

Effective date: 20060628

PD2B A search report has been drawn up
V1 Lapsed because of non-payment of the annual fee

Effective date: 20110601